Scientists who work in mycology — the study of fungi — say there is precious little money available to study Candida auris, according to an article on the STAT News website.
Candida auris is making news for its ability to resist multiple antifungal drugs and settle into hospital rooms so persistently it can take renovations to get rid of it.
The head of mycotic diseases at the Centers for Disease Control and Prevention (CDC) acknowledged his field hasn’t attracted the same kind of research dollars as other pathogens.
A high proportion of people who have been diagnosed with C. auris have died — the CDC estimates it’s between 30 percent and 60 percent.
Every Detail Matters: A Patient's Story of Healing, Hope and Healthcare Facilities
Geisinger Wyoming Valley Medical Center Tops Off New 11-Story Tower
PAM Health Announces Plans for Medical Rehabilitation Hospital in North Carolina
3 Ways to Minimize Disruption During Construction in Healthcare
St. Luke's University Health Network to Open Heart Hospital in October